Jason Carroll

Jason Carroll

Net worth: 9 M $ as of 31/05/2026

Consumer Services
Health Technology
Consumer Non-Durables

Profile

Jason Carroll is currently Chief Executive Officer at Tryp Therapeutics, Inc. since 2023, Chief Executive Officer, Director & MD at Entropy Neurodynamics Ltd. since 2024, and Non-Executive Chairman at Island Pharmaceuticals Ltd. starting in 2025.
Formerly, Mr. Carroll was Managing Director at Inova Pharmaceuticals (Philippines), Inc. from 2017 to 2023,.
Managing Director at Johnson & Johnson (Vietnam) Co. Ltd. from 2014 to 2017, and General Manager at Janssen Pharmaceutica (Philippines) from 2012 to 2014.
Education includes undergraduate studies at Flinders University and an MBA from Deakin University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
03/12/2025 32,074,930 ( 10.84% ) 9 M $ 31/05/2026

Jason Carroll active positions

CompaniesPositionStart
ISLAND PHARMACEUTICALS LIMITED Chairman 02/07/2025
Chief Executive Officer 01/10/2023

Former positions of Jason Carroll

CompaniesPositionEnd
Corporate Officer/Principal 01/03/2017
See the detail of Jason Carroll's experience

Training of Jason Carroll

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

8

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Consumer Services

Consumer Services

Consumer Non-Durables

Health Technology

Health Technology